 but they are hyper-technical. And what we could do is ferret out real-time information for agencies, for OIGs to pursue leads. And there's that preventative side, which goes to the agency. So we say, we found these abnormalities. These are things you should be looking for, agency, before you spend this money. That is a huge piece that we can do. But also, once the money has gone out, we can give additional data sets to individual IGs and say, hey, look, this is abnormal because